4//SEC Filing
Woolson Daniel 4
Accession 0001698998-24-000001
CIK 0000883984other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:35 PM ET
Size
21.1 KB
Accession
0001698998-24-000001
Insider Transaction Report
Form 4
Woolson Daniel
VP, GM-Infusion Capital
Transactions
- Tax Payment
Common Stock
2024-03-08$104.52/sh−894$93,441→ 14,771 total - Exercise/Conversion
Common Stock
2024-03-08+2,020→ 15,665 total - Exercise/Conversion
Common Stock
2024-03-07+5,792→ 16,209 total - Tax Payment
Common Stock
2024-03-07$105.39/sh−2,564$270,220→ 13,645 total - Exercise/Conversion
Common Stock
2024-03-07+966→ 10,843 total - Exercise/Conversion
Performance Shares
2024-03-08−2,020→ 0 totalExercise: $0.00From: 2023-03-08Exp: 2024-03-08→ Common Stock (2,020 underlying) - Tax Payment
Common Stock
2024-03-07$105.39/sh−426$44,896→ 10,417 total - Exercise/Conversion
Common Stock
2024-03-07−966→ 966 totalExercise: $0.00From: 2023-03-07Exp: 2025-03-07→ Common Stock (966 underlying) - Exercise/Conversion
Performance Shares
2024-03-07−5,792→ 0 totalExercise: $0.00Exp: 2024-03-07→ Common Stock (5,792 underlying) - Award
Common Stock
2024-03-08+6,459→ 6,459 total→ Common Stock (6,459 underlying)
Footnotes (8)
- [F1]These securities are Restricted Stock Units.
- [F2]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F3]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- [F4]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
- [F5]These are restricted stock units that fully vest 3 years from the grant date.
- [F6]There is neither a purchase price nor an exercise price for the PRSUs.
- [F7]These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
- [F8]These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
Documents
Issuer
ICU MEDICAL INC/DE
CIK 0000883984
Entity typeother
Related Parties
1- filerCIK 0001698998
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:35 PM ET
- Size
- 21.1 KB